FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Chlorzoxazone (PARAFON FORTE DSC) 500 mg Caplets
Status: Discontinuation
»Therapeutic Categories:

Janssen Pharmaceuticals (New 10/16/2014)

Company Contact Information:
800-526-7736

Presentation Posting Date Related Information
PARAFON FORTE® DSC 500 mg caplets 10/16/2014 The decision to discontinue (delist) is due to a business decision based on low market demand. Other versions of chlorzoxazone remain available.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English